Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion type Assertion NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_head.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion description "[From the standpoint of a clinically useful primary tumor risk factor for predicting occult disease, vascular invasion by the tumor and percentage of embryonal carcinoma component in the tumor are more useful than P53 immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_provenance.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion evidence source_evidence_literature NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_provenance.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion SIO_000772 8015085 NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_provenance.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion wasDerivedFrom befree-20150227 NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_provenance.
- NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_assertion wasGeneratedBy ECO_0000203 NP751373.RA95X-K-eAxrmni47G3Gw96HpfiKAS8P1xnGthe1xirEo130_provenance.